Citation profile for Grace Hampson

Grace Hampson : Citation Profile

Office of Health Economics

H index

i10 index

Citations

RESEARCH PRODUCTION:

Articles

Papers

RESEARCH ACTIVITY:

   4 years (2016 - 2020). See details.
   Cites by year: 6
   Journals where Grace Hampson has often published
   Relations with other researchers
   Recent citing documents: 2.    Total self citations: 2 (7.41 %)

MORE DETAILS IN:

EconPapers

ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pha1219
   Updated: 2025-12-20    RAS profile: 2021-07-12
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Grace Hampson.

Is cited by:

Mossialos, Elias (2)

Shah, Koonal (1)

Graf von der Schulenburg, Johann (1)

Gu, Yuanyuan (1)

Cites to:

Devlin, Nancy (4)

Towse, Adrian (3)

Moscone, Francesco (3)

Baltagi, Badi (3)

Claxton, Karl (2)

Karlsberg Schaffer, Sarah (2)

Karlsberg, Sarah (2)

Oliveira Martins, Joaquim (2)

Breyer, Friedrich (2)

Tsuchiya, Aki (2)

Sen, Anindya (2)

Main data

Where Grace Hampson has published?

Journals with more than one article published	# docs
Applied Health Economics and Health Policy	3

Working Papers Series with more than one paper published	# docs
Briefing / Office of Health Economics	4

Recent works citing Grace Hampson (2025 and 2024)

Year	Title of citing document
2025	Overcoming the “valleys of death” in advanced therapies: The role of finance. (2025). Cosma, Simona ; Pennetta, Daniela ; Rimo, Giuseppe. In: Social Science & Medicine. RePEc:eee:socmed:v:366:y:2025:i:c:s0277953624010931. Full description at Econpapers \|\| Download paper
2024	Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally. (2024). Fischer, Stefan ; Vogler, Sabine ; Haasis, Manuel Alexander ; Habimana, Katharina. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:22:y:2024:i:5:d:10.1007_s40258-024-00888-y. Full description at Econpapers \|\| Download paper

Year

Title of citing document

2025

Overcoming the “valleys of death” in advanced therapies: The role of finance. (2025). Cosma, Simona ; Pennetta, Daniela ; Rimo, Giuseppe. In: Social Science & Medicine. RePEc:eee:socmed:v:366:y:2025:i:c:s0277953624010931.

Full description at Econpapers || Download paper

2024

Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally. (2024). Fischer, Stefan ; Vogler, Sabine ; Haasis, Manuel Alexander ; Habimana, Katharina. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:22:y:2024:i:5:d:10.1007_s40258-024-00888-y.

Full description at Econpapers || Download paper

Works by Grace Hampson:

Year	Title	Type	Cited
2016	“New Age” Decision Making in HTA: Is It Applicable in Asia? In: Briefing. [Full Text][Citation analysis]	paper	0
2017	Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies In: Briefing. [Full Text][Citation analysis]	paper	1
2017	How can HTA meet the needs of health system and government decision makers? In: Briefing. [Full Text][Citation analysis]	paper	0
2017	Transferability of HTA In: Briefing. [Full Text][Citation analysis]	paper	0
2017	What Determines the Health Care Expenditure of High Income Countries? A Dynamic Estimation In: Applied Economics and Finance. [Full Text][Citation analysis]	article	0
2017	A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact? In: Applied Health Economics and Health Policy. [Full Text][Citation analysis]	article	4
2020	A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance In: Applied Health Economics and Health Policy. [Full Text][Citation analysis]	article	3
2020	Authors’ Reply to Hays: “A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance” In: Applied Health Economics and Health Policy. [Full Text][Citation analysis]	article	2
2019	Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare In: The European Journal of Health Economics. [Full Text][Citation analysis]	article	14
2018	Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL) In: PharmacoEconomics - Open. [Full Text][Citation analysis]	article	1